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trendS in the induStry
The dairy industry worldwide has achieved many significant 
advances over the last fifty years, with knowledge-based 
genetic selection and optimised nutrition playing important 
roles in the delivery of increased milk yields of improved 
quality in most breeds (Shook 2006). Increasingly, the 
health and welfare of dairy cattle is seen as vital to 
maximise profitability and to enhance public perception 
of modern dairy systems (Kelton 2006; Mulligan et al. 
2006). The next few decades are likely to present complex 
challenges for dairy farmers. Many of these challenges 
will result from national or international policies and 
from commercial decisions made by leaders in different 
countries around the world. 
The world population is anticipated to reach nine billion 
people by 2050. The highest rate of growth is likely to 
be in developing countries in Africa and Asia, while the 
population of continents such as Europe should remain 
relatively stable (UN 2004).  More food than that which is 
currently being produced will be required to feed the world 
population in the future. The rate of growth in demand 
for agricultural products has declined from 2.2% per year 
over the last 30 years to an anticipated 1.5% per year 
until 2030 (FAO 2002). Growth is largely comprised of a 
higher demand for meat and milk products by increasingly 
wealthy countries such as India and China (Beghin 2006).  
The increased demand for products derived from livestock 
is not however restricted to richer countries, as in some 
of the poorest communities in the world, production of 
crops or vegetables are unsustainable, resulting in heavy 
reliance on milk and meat (Ahmed et al. 2002). In many 
of these countries there is an increasing awareness of 
the benefits to humans of consumption of even very small 
amounts of protein, especially by the young (Bhargava 
2000) and the immunocompromised (Chevalier et al. 
1998).
The world is now a global marketplace with many primary 
commodities and processed products travelling thousands 
of miles from production to consumption. The incentives 
for production are evolving with the decoupling of EU 
subsidies for meat production, the changes in handling of 
milk quota within the EU, and the ongoing negotiations on 
world trade under the General Agreements on Tariffs and 
Trade (www.wto.org). The UK was 59.3% self-sufficient 
in food production in 2008, in comparison to 70.6% 
between 1995 and 1997 (DEFRA 2008). While this trend 
towards reduced self-sufficiency was seen as acceptable 
by some government departments, more recent debate 
has suggested that the UK public may be increasingly 
interested in issues of food security and supply. The last 
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The global dairy industry, the predominant pathogens causing mastitis, our understanding of mastitis pathogens and the host response 
to intramammary infection are changing rapidly. This paper aims to discuss changes in each of these aspects. Globalisation, energy 
demands, human population growth and climate change all affect the dairy industry. In many western countries, control programs 
for contagious mastitis have been in place for decades, resulting in a decrease in occurrence of Streptococcus agalactiae and 
Staphylococcus aureus mastitis and an increase in the relative impact of Streptococcus uberis and Escherichia coli mastitis. In some 
countries, Klebsiella spp. or Streptococcus dysgalactiae are appearing as important causes of mastitis. Differences between countries 
in legislation, veterinary and laboratory services and farmers’ management practices affect the distribution and impact of mastitis 
pathogens. For pathogens that have traditionally been categorised as contagious, strain adaptation to human and bovine hosts has been 
recognised. For pathogens that are often categorised as environmental, strains causing transient and chronic infections are distinguished. 
The genetic basis underlying host adaptation and mechanisms of infection is being unravelled. Genomic information on pathogens 
and their hosts and improved knowledge of the host’s innate and acquired immune responses to intramammary infections provide 
opportunities to expand our understanding of bovine mastitis. These developments will undoubtedly contribute to novel approaches to 
mastitis diagnostics and control. 
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few years have seen a decline in the milk price in the UK. 
In the spring of 2007, prices began to increase and a price 
of 25.62 pence per litre was reported in February 2008.  
The reasons for this relatively sudden increase in price 
probably included flooding in the UK, concern about the 
reliability of supply from major retailers and an increase 
in global demand for liquid milk and dairy products (www.
defra.gov.uk).
Current concerns about global warming and the adverse 
effect of greenhouse gases have influenced the perception 
of livestock farming, including the dairy industry. 
Approximately 10% of the total EU greenhouse gas 
emission has been attributed to agriculture (Lovett et al. 
2006). Dairy cattle have also been associated with poor 
water quality arising from nitrate and phosphate excretion 
in some heavily-grazed areas. Opinions expressed on the 
competition between the use of grain as foodstuffs for 
humans or cattle, or for biofuels are intense and varied, 
and are at least in part driven by a 60% increase in cereal 
prices since 2005 (Müller et al. 2008). The significant 
demand for grain for whatever purpose adds pressure to 
an already severely pressurised dairy industry. This is 
likely to lead to further reductions in farm numbers with 
a resulting increase in the average herd size in surviving 
units. Climate change has been predicted to affect human 
morbidity and mortality significantly (Patz et al. 2005) 
and is likely to reduce the area of landmass available 
for agricultural purposes due to drought or flooding 
in many regions of the world.  The Intergovernmental 
Panel on Climate Change (IPCC) has published detailed 
assessments of the effects, possible causes and options 
for mitigation of climate change (www.ipcc.ch). Yet another 
possible factor potentially adversely affecting production 
and trade of milk and milk products is the risk of 
agroterrorism aimed at the contamination or adulteration 
of food producing animals or their products (Wein and Liu 
2005; Buttars et al. 2006).
In Europe and North America, current market demand 
and price for organic milk encourage dairy producers to 
consider organic production to improve the economic 
viability of their farm operations (Rotz et al. 2007). Milk 
from herds managed organically or conventionally, with or 
without use of recombinant bovine somatotropin (rbST), is 
similar in composition (Ellis et al. 2006, 2007; Vicini et 
al. 2008). There are, however, perceived nutritional and 
taste benefits among consumers of organic milk (Hill and 
Lynchehaun 2002). Environmental and health benefits are 
also cited as reasons for consumption of organic milk (Hill 
and Lynchehaun 2002), and consumers are willing to pay 
a high price for organic or rbST-free milk (American Farm 
Bureau 2008). On the other hand, environmental benefits 
as well as animal health benefits have been attributed 
to use of rBST in milk production (Allore and Erb 2000; 
Capper et al. 2008). Animal health did not appear to 
differ between organic and non-organic farms in the UK 
(Langford et al. 2009). Udder health was better in organic 
than conventional herds in Sweden (Hamilton et al. 2006), 
whereas poor udder health caused more culling in organic 
than conventional herds in Switzerland (Roesch et al. 
2006).  Comparison of disease rates between conventional 
and organic herds can be difficult because perception and 
detection of disease is influenced by management system 
(Ruegg 2008). Despite the media attention devoted to 
organic dairy products and large relative increases in 
demand for organic dairy products, consumption of organic 
products is mostly limited to affluent consumers, and 
organic consumption constitutes a small segment of total 
dairy consumption (Hill and Lynchehaun 2002).
The dilemma, which the dairy industry will have to face, is 
how to maximise production without compromising welfare, 
while reducing the impact of carbon emissions from dairy 
cattle. An important aspect of achieving these aims is to 
focus on overall lifetime productivity of cattle, rather than 
on traditional annual targets (VanRaden 2004). To achieve 
this aim, a reduction in morbidity and mortality due to 
preventable and prevalent endemic diseases is needed, 
one such disease being mastitis. If this is to become a 
reality, increased efforts are required in the speed and 
accuracy of detection of mastitis, better targeting of 
therapy, and improved management and decision making 
in prevention of exposure to pathogens and avoidance of 
significant risk factors for disease (LeBlanc et al. 2006). 
If successful, a holistic approach to preventing and 
controlling mastitis may benefit communities across the 
world, in both nutritional and environmental terms.
trendS at pathogen leVel
In most countries, the major mastitis pathogens are 
Streptococcus agalactiae, Streptococcus dysgalactiae 
and Streptococcus uberis, Staphylococcus aureus, 
and Escherichia coli. The word “major” reflects their 
considerable impact on cow health, milk quality and 
productivity. When the standard mastitis prevention 
programme was developed in England (Neave et al. 1969), 
Gram-positive pathogens such as Streptococcus and 
Staphylococcus species were the predominant causative 
agents of mastitis. Many infections caused by these 
pathogens were subclinical and chronic. The standard 
mastitis prevention programme aimed to reduce the 
prevalence of such infections by limiting the number of 
new infections and the duration of infections, recognizing 
that incidence and duration are the driving forces behind 
prevalence (Dodd et al. 1969). Implementation of these 
measures lead to a reduction in prevalence of Strep. 
agalactiae, Strep. dysgalactiae, Staph. aureus, and, to 
a lesser extent, Strep. uberis in individual herds (Neave 
et al. 1969). As more herds implement the standard 
control measures, pathogen populations at regional or 
national level start to shift. In some European countries, 
e.g. Belgium, Denmark, Norway and the UK, occurrence 
of Strep. agalactiae is now sporadic (Andersen et al. 
2003; Østerås et al. 2006; Bradley et al. 2007; Piepers 
et al. 2007). In other areas, Strep. agalactiae is still quite Irish Veterinary Journal Volume 62 Supplement
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common, e.g. in parts of Europe [Germany: 29% of herds 
positive (Tenhagen et al. 2006)] and the Americas [Brazil: 
60% of herds positive (Duarte et al. 2004); Uruguay: 
11% of herds positive (Gianneechini et al. 2002); New 
York, USA: 10% of cows positive (Wilson et al. 1997)]. 
Subclinical mastitis constitutes a major source of 
economic loss for dairy farms due to unrealised production 
potential and decreased milk quality (Hortet and Seegers, 
1998; Huijps et al. 2008). The feasibility (Neave et al. 
1969) and economic benefit (Yamagata et al. 1987; 
Edmondson 1989; Erskine and Eberhart 1990) of Strep. 
agalactiae control have been demonstrated repeatedly. 
This should provide every producer with the incentive to 
control Strep. agalactiae mastitis, and to use resources 
for milk production in a more efficient manner. In reality, 
motivation of producers to control mastitis may depend on 
bonus and penalty systems (Dekkers et al. 1996; Allore 
and Erb 1998; Nightingale et al. 2008). Regulatory limits 
for bulk milk somatic cell counts (BMSCC), which reflect 
mastitis prevalence in a herd (Eberhart et al. 1982), differ 
between countries or are entirely lacking. In Colombia, for 
example, the dairy industry cannot keep up with current 
demand. The need for milk quantity outweighs the need 
for milk quality, and there is currently no legislation or 
laboratory capacity to regulate and measure BMSCC in 
Colombia. Producers’ ability to control mastitis will depend 
on access to knowledge, diagnostic facilities, and animal 
health products. An increasing number of cows are milked 
in Latin America or by Hispanic milkers in the USA. To 
provide Spanish-speakers with access to information on 
mastitis control, a growing number of organisations provide 
bi-lingual milker training and translation of educational 
materials (NMC 2008; Quality Milk Production Services 
2008; University of Wisconsin 2008).  
In parallel with the decreases in national average BMSCC 
and prevalence of Strep. agalactiae, a decrease in 
prevalence of Staph. aureus has been seen in some 
countries. In Finland, BMSCC decreased from 320,000 
cells/ml in 1990 to 180,000 cells/ml in 1995 and 
Staph. aureus prevalence decreased from 31% to 17% of 
isolations (Myllys et al. 1998). As BMSCC and prevalence 
of major pathogens decrease, the relative importance 
of other organisms, particularly coagulase negative 
staphylococci (CNS), increases. In the Netherlands, the 
prevalence of CNS among bacterial isolates from milk 
samples increased from 16.2% in 1999 to 42.2% in 2004 
for subclinical mastitis, and from 7.3% to 14.1% for clinical 
mastitis (Sampimon et al. 2007). CNS are now among the 
most commonly isolated organisms from milk samples of 
cows with subclinical mastitis in many countries (Rajala-
Schultz et al. 2004; Østerås  et al. 2006; Tenhagen et al. 
2006; Bradley et al. 2007). In 2007, the first international 
symposium on CNS in bovine mastitis was organised, 
reflecting the increasing recognition of the potential 
importance of this group of pathogens (De Vliegher et 
al. 2009). Molecular methods for identification of CNS 
provide accurate tools for epidemiological studies at CNS 
species level and future development of species-specific 
recommendations for treatment and prevention of CNS 
mastitis (Zadoks and Watts 2009).
Despite improvements in control of subclinical mastitis, 
control of clinical mastitis continues to constitute a major 
challenge (Hillerton et al. 1995). The main organisms 
associated with clinical mastitis in England and Wales are 
E. coli and Strep. uberis (Milne et al. 2002; Peeler et al. 
2003; Bradley et al. 2007). A steady increase in relative 
importance of Strep. uberis can be seen over the decades, 
with 15, 17, 21 and 24.5% of clinical mastitis cases 
attributed to this species in 1969, 1980, 1993 and 2005, 
respectively (Neave et al. 1969; Bramley 1984; Hillerton 
et al. 1993; Bradley et al. 2007). When accounting for 
the incidence of clinical mastitis per 100 cows per year, 
however, the absolute incidence of Strep. uberis mastitis 
decreased from 21 cases per 100 cows in 1969 (Neave 
et al. 1969), to only seven or eight cases per 100 cows 
in 1980 (Bramley 1984) and 1993 (Hillerton et al. 1993). 
In recent years, reported Strep. uberis incidence has 
increased again, with 16 cases/100 cows/year reported 
for 2005 (Bradley et al. 2007). The second most common 
group of pathogens causing clinical mastitis in England 
and Wales consists of E. coli and other Enterobacteriaceae 
(Milne et al. 2002; Bradley et al. 2007). In New Zealand, 
as in the UK, Strep. uberis is the most common pathogen 
associated with clinical mastitis, but in contrast to the 
situation in the UK, E. coli mastitis is rarely observed 
(McDougall 2003). In Norway, neither Strep. uberis nor E. 
coli are commonly found. Rather, Staph. aureus and Strep. 
dysgalactiae are the most common causes of clinical 
mastitis (Whist et al. 2007). Staphylococcus aureus is 
the main pathogen associated with clinical mastitis in The 
Netherlands, followed by E. coli and Strep. dysgalactiae 
(Barkema et al. 1998). Mycoplasma (González and Wilson 
2003; Fox et al. 2005) and Klebsiella (Hoe and Ruegg 
2005; Munoz et al. 2007; Paulin-Curlee et al. 2007) 
mastitis are major concerns in the USA. Faecal shedding 
of Klebsiella is thought to contribute to exposure and 
mastitis incidence in dairy herds in the USA (Munoz et al. 
2006; 2007). By contrast, Klebsiella mastitis outbreaks 
are only occasionally reported from Europe and they are 
predominantly associated with contaminated sawdust 
bedding (Vecht et al. 1987; Sampimon et al. 2006). 
Mycoplasma mastitis is only occasionally reported from 
Europe (Blackburn et al. 2007; Tolboom et al. 2008). 
Increasingly, milk samples from clinical mastitis cases are 
culture-negative. Culture-negative samples were obtained 
from approximately 25 to 30% of clinical cases in studies 
in the UK (Milne et al. 2002; Bradley et al. 2007) and the 
USA (Hoe and Ruegg 2005). It has been proposed that 
culture negative cases should be attributed to coliform 
organisms, and that our diagnostic methods and criteria, 
which were developed for detection of chronic, subclinical 
infections, need to be updated to be appropriate for the 
changed spectrum of mastitis pathogens (Bradley et al. 
2005). Use of PCR based methods may also contribute Irish Veterinary Journal Volume 62 Supplement 62
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to improved mastitis diagnostics, e.g., through increased 
sensitivity of detection of Staph. aureus (Graber et al. 
2007) or organisms that are non-viable or difficult to 
culture (Barlow et al. 2008).
Considering that different pathogens are the predominant 
cause of clinical mastitis in different countries, mastitis 
controls will need to be developed to meet the specific 
requirements of an individual country or segment of the 
dairy industry. Some mastitis control strategies, e.g., 
vaccination against coliform mastitis, are widely adopted 
in one country (USA) but may not be available in other 
countries (e.g, The Netherlands) and not even relevant 
elsewhere (New Zealand, Norway). Targeted intervention 
strategies are being developed and implemented in a 
number of countries (Green et al. 2007; Lam et al. 2007; 
www.countdown.org.au). Significant improvements in 
udder health have been reported (Green et al. 2007), but 
adoption and success rates depend on farmer motivation 
and behaviour (Lam et al. 2007). Insight into socio-
economic factors that motivate farmers to control mastitis 
may be as important as scientific or technical knowledge 
to improve uptake of mastitis control measures (Lam et al. 
2007).
trendS at Strain leVel
The application of molecular or DNA-based methods in 
mastitis research and diagnostics has contributed to 
an increased understanding of mastitis epidemiology 
and control options. Using these methods, isolates 
belonging to a bacterial species can be differentiated 
at the subspecies or strain level, allowing for improved 
recognition of sources and transmission routes of 
pathogens (Zadoks and Schukken 2006). 
Streptococcus agalactiae is the quintessential contagious 
mastitis pathogen. It mostly causes subclinical infections 
and implementation of the standard mastitis prevention 
programme has all but eradicated this organism from 
several countries in Western Europe. Occasionally, clinical 
Strep. agalactiae mastitis is observed in herds with good 
control of contagious mastitis, as evidenced by low BMSCC 
(< 150,000 cells/ml) (Barkema et al. 1998). Clinical 
episodes of Strep. agalactiae mastitis can also be induced 
experimentally (Jensen 1982). They are generally short-
lived and do not result in transmission of the pathogen 
in the herd. Occurrence of Strep. agalactiae in bulk tank 
milk from herds without evidence for transmission or 
presence of the pathogen in individual cow has been 
attributed to cross contamination between loads of 
milk (Andersen et al. 2003). Other authors attribute the 
occurrence of incidental clinical mastitis and the presence 
of Strep. agalactiae in bulk tank milk obtained from Strep. 
agalactiae-free animals to introduction of human Strep. 
agalactiae strains (Zadoks and Schukken 2006). Strep. 
agalactiae or Group B Streptococcus (GBS) is highly 
prevalent in humans, with carriage rates of 30% or more 
in the urogenital and distal gastrointestinal tracts of 
women (Manning et al. 2000; Meyn et al. 2002; Hansen 
et al. 2004) and close to 25% in men (Manning et al. 
2000). Maternal carriage of Strep. agalactiae may result 
in neonatal infection, with subsequent sepsis, meningitis, 
permanent neurological damage, or death of newborns. 
Human and bovine isolates largely constitute genetically 
distinct subpopulations within the bacterial species 
(Bisharat et al. 2004; Bohnsack et al. 2004; Dogan et al. 
2005; Sukhnanand et al. 2005). Canine and feline strains 
of Strep. agalactiae are genetically similar to human rather 
than bovine strains (Yildirim et al. 2002). A virulent human 
strain of Strep. agalactiae that is significantly associated 
with invasive neonatal disease has evolved from bovine 
strains of Strep. agalactiae (Bisharat et al. 2004). To 
prevent emergence of additional human-pathogenic 
strains from a bovine Strep. agalactiae reservoir, it has 
been suggested that the pathogen should be eradicated 
from the cattle population (Hillerton et al. 2004). Strep. 
agalactiae is highly prevalent in humans but relatively rare 
in UK dairy herds, and its presence in dairy herds may be 
the result or the cause of its presence in humans. Thus, 
it is uncertain whether elimination from cattle would be a 
cost-effective way to prevent human disease due to Strep. 
agalactiae. 
Staphylococcus aureus has been more difficult to control 
using the standard mastitis prevention programme than 
Strep. agalactiae. This is due in part to difficulty in 
diagnosing and curing Staph. aureus infections (Barkema 
et al. 2006). In addition, Staph. aureus can be found in 
many sources, including bovine skin, non-bovine animals 
and humans, flies, and the barn environment. Strain 
typing studies show that some cases of Staph. aureus 
mastitis are not due to contagious transmission but 
environmental in origin (Kapur et al. 1995; Rivas et al. 
1997; Zadoks et al. 2000; Joo et al. 2001). The incidence 
of environmental Staph. aureus infections would not 
be affected by implementation of the standard mastitis 
prevention programme. Across countries and continents, 
more than 85% of bovine Staph. aureus mastitis is 
caused by a genetically closely related subpopulation of 
the species (Fitzgerald et al. 1997; Smith et al. 2005), 
which is adapted to the bovine host or, more specifically, 
to the bovine udder (Herron-Olson et al. 2007). Strains 
of Staph. aureus differ in their ability to spread from cow 
to cow (Smith et al. 1998; Zadoks et al. 2002) or to 
provoke an increase in somatic cell count (Zadoks et al. 
2002), in impact on milk yield (Middleton and Fox 2002), 
and in response to antimicrobial treatment (Barkema 
et al. 2006). The full genome sequences of a number 
of Staph. aureus strains are now available (Baba et al. 
2008). This allows for detailed examination of genetic 
elements or proteins that may be responsible for host or 
tissue adaptation (Herron-Olson et al. 2007). An improved 
understanding of such components may contribute to the 
development of new intervention strategies to control 
Staph. aureus mastitis (Fitzgerald et al. 2000; Mullarky 
et al. 2001). As for Strep. agalactiae, a virulent strain Irish Veterinary Journal Volume 62 Supplement
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that poses a potential human health risk has arisen from 
a subpopulation of bovine Staph. aureus (Guinane et al. 
2008). In addition, methicillin-resistant Staph. aureus in 
dairy cattle and cattle farmers is an increasing concern 
(Juhász-Kaszanyitzky et al. 2007; Moon et al. 2007; Van 
Loo et al. 2007). These findings lend new urgency to the 
need to improve control of Staph. aureus mastitis. 
Whilst Staph. aureus is a contagious pathogen more than 
an environmental pathogen, the reverse is true for Strep. 
uberis (Zadoks 2007). Strain typing studies have revealed 
large genetic heterogeneity among Strep. uberis isolates 
obtained from animals within a single herd, particularly in 
New Zealand (Douglas et al. 2000; Wieliczko et al. 2002; 
McDougall et al. 2004; Pullinger et al. 2006), which proves 
absence of cow-to-cow transmission. In other studies, 
however, predominant strains of Strep. uberis have 
been observed within herds (Zadoks et al. 2003; Coffey 
et al. 2006), which might be explained by contagious 
transmission. In one outbreak, the milking machine 
was identified as a likely fomite for such transmission 
(Zadoks et al. 2003). Alternative explanations for strain 
predominance include overrepresentation of a strain 
in the environment, or host-adaptation of a subset of 
the Strep. uberis population (Zadoks and Schukken 
2006). In studies from New Zealand, several common 
environmental strains were underrepresented among 
mastitis causing isolates (Lopez-Benavides et al. 2007; 
Pullinger et al. 2006), which argues against environmental 
strain predominance as a full explanation for strain 
predominance among bovine isolates. Modern genomic 
and proteomic methods enable us to explore the host-
adaptation hypothesis (Zadoks 2007) as well as potential 
vaccine targets (Leigh et al. 2004). They may also help 
us understand why some Strep. uberis infections respond 
well to antimicrobial treatment, whereas others do not 
respond to prolonged intramammary therapy (Milne et al. 
2005). In vitro, adherence of Strep. uberis and subsequent 
invasion and survival in mammary epithelial cells has been 
observed (Tamilselvam et al. 2006). Such processes could 
explain persistence of infection and treatment failures, 
but it is uncertain whether these observations are a 
reflection of events that take place in vivo (Leigh 1999). 
Use of infection models in animals will help to assess 
the relevance of these experiments and their potential 
contribution to our knowledge of disease causation and 
control. 
Where Strep. agalactiae may be considered the 
quintessential contagious pathogen, E. coli can be 
considered the quintessential environmental pathogen 
and no evidence for cow-to-cow transmission of E. coli 
has been published yet. There is, however, emerging 
evidence for host-adaptation of E. coli. Most E. coli 
infections occur in early lactation in high producing cows, 
when immunosuppression through metabolic deficiencies 
(Suriyasathaporn et al. 2000a) or extremely low SCC 
(Suriyasathaporn et al. 2000b; Peeler et al. 2003) lowers 
the host’s resistance. Infections tend to result in acute 
and often severe clinical mastitis with removal of the 
pathogen or removal of the cow as the two most likely 
outcomes. In other animals, however, recurrent episodes 
of clinical mastitis are observed, with considerable 
economic loss as a result (Bar et al. 2007). Recurrent 
clinical episodes may be due to cure and reinfection of a 
susceptible host. Alternatively, the bacteria and the cow 
may survive simultaneously, and subclinical episodes of a 
persistent infection may alternate with clinical episodes. 
Strain typing studies have confirmed the existence of 
both mechanisms (Döpfer et al. 1999, 2000; Bradley 
and Green 2001; Dogan et al. 2006). Persistence of E. 
coli infections is associated with invasion and survival 
of E. coli inside mammary epithelial cells in vitro (Dogan 
et al. 2006), a mechanism similar to that proposed for 
Strep. uberis. Virulence genes typically associated with 
invasion of diarrhoeagenic and uropathogenic pathogenic 
E. coli did not account for the invasive behaviour of 
mastitis-associated E. coli strains and the mechanism 
of invasion is as yet undetermined (Dogan et al. 2006). 
Whole genome comparison of E. coli strains associated 
with different disease syndromes may reveal genes that 
are specific to mastitis associated E. coli. Some cases of 
clinical E. coli mastitis that are observed in lactation are 
the result of infections that took place in the dry period 
(Bradley and Green 2000), implying that the dry period 
rather than peak lactation can be a critical time for control 
of E. coli mastitis. Use of internal teat sealants does 
not reduce the risk of dry-period infections with coliform 
bacteria significantly (Berry and Hillerton 2002; 2007) 
Through use of genomic and proteomic tools, it will be 
possible to further explore how different subpopulations 
of pathogens differ in mechanisms of disease causation 
and transmission. A more developed understanding of 
the pathogenesis and epidemiology of bovine mastitis 
will provide new approaches aimed at improvements in 
mastitis control. Rapid, effective, and increasingly cost-
effective methods of sequencing pathogen genomes have 
already contributed new information to our understanding 
of host-pathogen interactions in mastitis. Manipulation 
of mastitis pathogens using molecular methods such 
as mutagenesis (Brouillette and Malouin 2005), and 
measurement of messenger RNA (transcriptomics), 
proteins or peptides (proteomics) and networks of 
metabolites (metabolomics), provide further opportunities 
to investigate mastitis pathogenesis at pathogen and host 
level (Lippolis and Reinhardt 2005; Smolenski et al. 2007; 
Taverna et al. 2007; Boehmer et al. 2008).
trendS at hoSt leVel
In many countries, the emphasis on improving dairy 
production has been to focus on breeds that have 
particularly high milk yields, especially Holstein, which 
is the most widespread dairy cattle breed, found in 128 
countries worldwide (FAO 2007). In the USA, fewer than 
5% of dairy cattle belong to breeds other than purebred Irish Veterinary Journal Volume 62 Supplement 64
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or grade Holsteins (McAllister 2002). There has been a 
decrease in the numbers of more traditional breeds such 
as Jersey and Guernsey and Alpine breeds, which have 
lower milk yields but better quality milk than the Holstein 
breed in terms of benefits to human health or processing 
qualities (Ellis et al. 2006; De Marchi et al. 2007; Kamiski 
et al. 2007). Selection of dairy cattle over the years has 
been based on phenotypic traits such as teat length, udder 
placement and ‘dairy type’, however, increased emphasis 
on selection of sires for traits such as predicated 
transmitting ability for somatic cell counts, an indirect 
measurement of mastitis susceptibility, and for economic 
traits such as profit index, total economic index and 
profitable life index, are becoming commonplace (Dekkers 
and Gibson 1998; Wicks and Leaver 2006). Selection of 
sires for these traits has increased the rate of change 
of phenotypic characteristics, for example milk yield and 
quality, however, this has occurred through selection of a 
relatively small number of very popular sires, especially 
within Holstein Friesians. In some animal species, 
selection of a small number of sires has been associated 
with genetic bottlenecks (Mikko and Andersson 1995; 
Rendo et al. 2004). This may result in reduced variation 
in the offspring, which may in turn have adverse effects 
on health and welfare. One gene complex which has 
been long recognised as being associated with mastitis 
susceptibility or resistance is the Major Histocompatibility 
Complex, where Class I (Vage et al. 1992) were found to 
be associated with health traits including measurements 
of somatic cell counts (Weigel et al. 1990) and Class II 
(Sharif et al. 2003) genes have been demonstrated as 
playing an important role in presenting antigen to cells of 
the immune system and in response of lymphocytes to 
mastitis pathogens (Park et al. 1993). More recently, other 
genes and gene complexes have been shown to play a role 
in the pathogenesis of mastitis, including Toll-like receptors 
(Opsal et al. 2008). 
In some countries, priorities such as the adaptability 
of cows to once a day milking or for specific systems 
including low input or extensive management, have led to 
selection for characteristics other than milk yield. There is 
increasing interest in cross-breeding dairy cattle such as 
Norwegian Reds with one or more breeds (e.g. Holstein 
Friesian and/or Normande, Montbeliarde; Heins et al. 
2006) in order to produce dairy cattle with reasonable 
production levels combined with a reduced susceptibility to 
some of the main production diseases including mastitis 
and endometritis (Heringstad et al. 2007). Changing 
breeding goals also reflect a growing public interest in 
sustainability of dairy cattle production, with consideration 
of market economic values and non-market values such 
as animal welfare (Oltenacu and Algers 2005; Nielsen et 
al. 2006). In contrast to the dominance of the Holstein 
breed in terms of cow numbers and contribution to dairy 
genetics, certain dairy breeds across the world have 
had their numbers reduced to such an extent, that their 
sustainability is threatened. One such example is the 
Modicana breed of cattle, originating in Sicily where they 
produce very high quality hard cheese: Ragusano (Licitra et 
al. 1998). It is important that a genetic resource for minor 
breeds is maintained in order to protect against extinction 
and to ensure that beneficial genes could be re-introduced 
to the dairy cattle population should they be identified 
as required. The uncertainty of the direction of the dairy 
industry in terms of supply and demand, and in light of 
potential environmental impacts, makes maintenance of 
diversity in dairy cattle particularly important.
Requirements for liquid milk and dairy products in 
developing countries will require development of more 
efficient dairying systems and investment in the 
application of modern technologies where appropriate. 
Maintenance of dairy cattle in developing countries poses 
many challenges, especially breeding cattle, which are 
resistant to many of the diseases with high mortality 
such as theileriosis and trypanosomiasis (Freeman et al. 
2004). In East Africa, dairy cattle are principally cross-
breeds between European Bos taurus dairy breeds, 
including Ayrshire, Friesian or Jersey, and indigenous 
Bos indicus cattle such as Boran or Zebu (Msanga et al. 
2000; Karimuribo et al. 2006). The Boran breed which is 
recognised for its relatively high milk yield compared to 
other cross-breeds, has been shown to be 3.4 times more 
likely to be affected by clinical and subclinical mastitis 
than the Tanzanian Shorthorn Zebu breed (Karimuribo et 
al. 2006). Selection of crossbred dairy cattle on the basis 
of greater milk yield may therefore need to be combined 
with an improvement in control programmemes for mastitis 
to ensure a sustainable industry.
Resistance to mastitis has been associated with both 
innate (Rainard and Riollet 2006) and acquired immunity 
(Kehrli and Harp 2001). Selection of cattle for breeding for 
mastitis resistance depends on measurement of humoral 
or cellular assays which are predicted as correlates of 
protection against intramammary infection (Dosogne et al. 
2002; Shkreta et al. 2004). It is increasingly recognised 
that different mastitis species induce very different 
inflammatory and immune responses. Examples include 
the very rapid and relatively short-lived influx of neutrophils 
following infection with the Gram negative organisms such 
as E. coli (Mehrzad et al. 2004) and the more gradual 
concentration of lymphocytes, including regulatory T cells 
in mammary glands infected with Staph. aureus (Chang 
et al. 2005). Host genetics affect disease incidence and 
severity, and pathogen genetics may influence the host 
genetic structure. Therefore, the evolutionary impact of the 
interaction between the host and its pathogens needs to 
be taken into consideration to fully appreciate implications 
of breeding strategies aimed at mastitis prevention 
(Detilleux 2009). 
Host responses to intramammary infection differ between 
pathogen species (Bannerman 2008; Bannerman et al. 
2004a, b) and pathogen strains. The ability of the host Irish Veterinary Journal Volume 62 Supplement
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to prevent establishment of new intramammary infections 
is determined in part by the ability of neutrophils to 
phagocytose and kill pathogens. Pathogen strains that 
evade neutrophil killing are more likely to establish 
infection than those that do not. In vitro, Staph. aureus 
strains that produce enterotoxins are not killed as 
efficiently as enterotoxin negative strains (Mullarky et 
al. 2001). In a large collection of Staph. aureus isolates 
from three continents, enterotoxin producing strains were 
overrepresented among isolates that caused clinical 
mastitis (Mullarky et al. 2001), suggesting that the 
inability of the host immune system to deal efficiently with 
these strains results in increased likelihood of clinical 
disease. Whether it is the enterotoxins themselves that 
affect the immune response, or other virulence factors 
encoded by the agr-loci that enterotoxin production tends 
to be associated with, is not fully understood (Mullarky 
et al. 2001). For Strep. uberis, differences between 
strains in their ability to cause clinical mastitis have 
also been associated with differences in their ability to 
resist phagocytosis and killing by host neutrophils (Leigh 
et al. 1990). Analysis of large international collections 
of Strep. uberis has shown that isolates that carry the 
hasA gene, which encodes hyaluronate synthase and 
contributes to capsule formation, are more likely to cause 
clinical mastitis than other isolates (Coffey et al. 2006; 
Pullinger et al. 2006; Tomita et al. 2008). Initially, it was 
thought that capsule mediates resistance of Strep. uberis 
to phagocytosis and killing by bovine neutrophils (Leigh 
1999), but later studies showed that the presence of 
capsule is not directly related to the bactericidal action 
of neutrophils (Field et al. 2003). Thus, the mechanisms 
underlying strain-specific host-immune responses to 
Staph. aureus and Strep. uberis remain to be elucidated. 
Mechanisms underlying strain specific interaction of 
pathogens with host mammary epithelial cells, as desribed 
for Strep. uberis (Matthews et al. 1994) and E. coli (Dogan 
et al. 2006) have not been identified either. Further 
studies are required to compare inter-strain variation in 
host response.
SuMMary and outlooK
While this manuscript describes the trends considered 
by the authors as impacting significantly on the dairy 
and veterinary industries, many aspects discussed 
also potentially relate to infections of the mammae of 
humans and identification of the causes and effects 
of intramammary disease in lactating women. Breast-
feeding mothers are at risk of clinical and possibly 
subclinical mastitis (Tomkins 2000; Foxman et al. 2002) 
and infectious mastitis is one of the main causes of 
premature weaning in lactating women (Delgado et al. 
2008). The current focus on ‘One Medicine’ by the 
Centres for Disease Control and Prevention in the USA 
and the promotion of this approach by the editors of 
the British Medical Journal and The Veterinary Record 
(Alder and Easton 2005) aims to combine research 
efforts on human and veterinary diseases to provide 
benefits to all mammals in terms of effective response 
to terrorism, diseases and natural disasters. Some of the 
trends appearing in mastitis in dairy cattle raise issues 
of comparative medicine in addition to the impact of the 
disease on the availability and benefits of milk to the 
human population.
Recent scientific developments, specifically in the areas 
of genomics and proteomics at host and pathogen 
level, provide exponentially growing opportunities for a 
deepening of our understanding of mastitis pathogenesis 
and epidemiology. Whilst it is hoped that such scientific 
understanding will contribute to mastitis control, social, 
economic and climatic trends are likely to be the main 
drivers behind changes in milk production systems and 
mastitis control. At herd level, motivation of farmers 
is an essential driver. At the national level, regulatory 
and economic incentives may be used to drive farmer 
motivation. At a global level, food and fuel needs and 
changes in human population size, wealth distribution, 
climate and land availability and use will be major forces 
in determining the future of agriculture and dairy farming. 
Although there are many uncertainties surrounding 
estimates in anticipated population, climate and land 
use changes, one thing is clear: more people will need 
to be provided with animal-based food products using 
fewer natural resources. Thus, there is an urgent need to 
increase the efficiency of milk production. Mastitis control 
is a step towards reaching that goal.  
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